Mild Autonomous Cortisol Secretion and Psychiatric Morbidity in Patients With Adrenal Tumors: A Cohort Study

Clicks: 15
ID: 332145
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #408 of 449 articles by views in the journal of clinical endocrinology & metabolism

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 449 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
CONTEXT: Mild autonomous cortisol secretion (MACS) in adrenal tumors (ATs) is associated with cardiometabolic disease, but its relationship with psychiatric morbidity is poorly defined. OBJECTIVE: To investigate psychiatric outcomes in relation to cortisol autonomy in patients with ATs. METHODS: Population-based retrospective cohort study of 3195 patients with a first benign AT diagnosis (2005-2018) and an available 1-mg dexamethasone suppression test (DST) result in the Stockholm Region, Sweden, identified via national registers and regional laboratories. Patients were classified as having MACS (DST >50 nmol/L) or non-functional AT (NFAT) (DST ≤50 nmol/L). Prevalent and incident psychiatric diagnoses and dispensed psychotropic medications were analyzed by logistic and Cox regression, adjusted for age, sex, and socioeconomic status. RESULTS: Of 3195 patients (median age, 64 years; 58.9% women), 1979 had NFAT and 1216 had MACS. Psychiatric disorders were more common with MACS (adjusted odds ratio, 1.35 [95% CI, 1.11-1.64]). Over 4.7 years' median follow-up, MACS was associated with higher incidence of psychiatric disorders (adjusted hazard ratio [aHR], 1.79 [1.43-2.23]), including anxiety, mood, and substance use disorders (aHR range, 1.41-2.50), with the highest point estimate among men younger than 65 years (aHR, 3.11 [1.87-5.18]). However, after correction for multiple comparisons only psychiatric disorders and substance use disorders remained significant. Findings were consistent across categorical and continuous cortisol measures. CONCLUSIONS: Psychiatric disorders were more common among patients with MACS than NFAT. These findings suggest that mild cortisol autonomy may contribute to psychiatric vulnerability and support consideration of psychiatric history and symptoms when assessing patients with ATs.
Reference Key
openalex_W7221526868 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hadis Mirzaei, Jonatan D. Lindh, Alexandra Falhammar, Merit Schaafsma, Buster Mannheimer, Henrik Falhammar
Are you one of these authors? Claim your profile
Journal the journal of clinical endocrinology & metabolism
Year 2026
DOI
10.1210/clinem/dgag419
URL
https://doi.org/10.1210/clinem/dgag419
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.